Therapeutic effects of restricted diet and exercise in obese patients with fatty liver

Journal of Hepatology

Volumn 27, Issue 1, 1997, Pages 103-107

  Ueno, Takato ^a   Sugawara, Hiroshi ^a   Sujaku, Koodo ^a   Hashimoto, Osamu ^a   Tsuji, Riko ^a   Tamaki, Seishu ^a   Torimura, Takuji ^a   Inuzuka, Sadataka ^a   Sata, Michio ^a   Tanikawa, Kyuichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diet therapy; Exercise therapy; Fatty liver; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CHOLINESTERASE; GLUCOSE; PROTEIN; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; DIET RESTRICTION; DIET THERAPY; ECHOGRAPHY; EXERCISE; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; OBESITY; PRIORITY JOURNAL; STEATOSIS; TOMOGRAPHY;

EID: 0030740659     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80287-5     Document Type: Article

References (23)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 67:1983;968-977.
2. Van Itallie TB. Health implications of overweight and obesity in the Unites States. Ann Intern Med. 103:1985;983-988.
3. Sherlock S, Dooley J. Nutritional and metabolic liver disease. Sherlock S, Dooley J. 9th edn. Diseases of the liver and biliary system. 408-433:1993;Blackwell Scientific Publications, London.
4. Schaffner F. Nonalcoholic fatty liver. Haubrich WS, Schaffner F, Berk JE. 5th edn. Gastroenterology. 1995;2246-2254 W.B. Saunders, Philadelphia.
5. Wanless IR, Lentz JS. Fatty liver hepatitis (steatopatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 12:1990;1106-1110.
6. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 67:1979;811-816.
7. Ito S, Tsukada Y, Motomura Y, Ichinoe A. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepato-Gastroenterol. 26:1979;90-97.
8. Ludwig J, Viggiano TR, Mcgill DB, Ott BJ. Nonalcoholic steatohepatitis. Mayo Clin Proc. 55:1980;434-438.
9. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol. 20:1989;594-598.
10. Powell EE, Cooksley GE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology. 11:1990;74-80.
11. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 107:1994;1103-1109.
12. Anderson JW, Hamilton CC, Brinkman-Kaplan V. Benefits and risks of an intensive very-low-calorie diet program for severe obesity. Am J Gastroenterol. 87:1992;6-15.
13. Yamamoto R, Inoue S, Saito M, Okamoto M, Okamura A, Takamura Y. Very-low-calorie-diet therapy in severe obesity. Am J Clin Nutr. 56:1992;299S-302S.
14. Froidevaux F, Schutz Y, Christin L, Jéquier E. Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period. Am J Clin Nutr. 57:1993;35-42.
15. Sweeney ME, Hill JO, Heller PA, Baney R, DiGirolamo M. Severe vs moderate energy restriction with and without exercise in the treatment of obesity: efficiency of weight loss. Am J Clin Nutr. 57:1993;127-134.
16. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chon Dis. 25:1972;329-343.
17. Oscai LB, Holloszy JO. Effects of weight changes produced by exercise, food restriction, or overeating on body composition. J Clin Invest. 48:1969;2124-2128.
18. Kukkonen K, Rauramaa R, Siitonen O, Hänninen O. Physical training of obese middle-aged persons. Ann Clin Res. 34:1982;80-85. (Suppl).
19. Diehl AM, Goodman Z, Ishak KG. Alcohol like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 95:1988;1056-1062.
20. Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med. 282:1970;829-834.
21. Brunelli E, Maccarri G, Jezequel AM, Orlandi F. Diagnostic value of the fibrosis of the terminal hepatic venule in fatty liver and chronic hepatitis due to ethanol or other aetiology. Liver. 5:1985;261-266.
22. Mavrelis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology. 3:1983;226-231.
23. Fiatarone JR, Coverdale SA, Batey RG, Farrell GC. Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. J Gastroenterol Hepatol. 6:1991;585-590.